Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting

키워드

참고문헌 (95)

1. Kreso A, "Evolution of the cancer stem cell model", Cell Stem Cell, 14, pp.275~291 (2014)
2. Bonnet D, "Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell", Nat Med, 3, pp.730~737 (1997)
3. Lapidot T, "A cell initiating human acute myeloid leukaemia after transplantation into SCID mice", Nature, 367, pp.645~648 (1994)
4. Al-Hajj M, "Prospective identification of tumorigenic breast cancer cells", Proc Natl Acad Sci U S A, 100, pp.3983~3988 (2003)
5. Medema JP, "Cancer stem cells: The challenges ahead", Nat Cell Biol, 15, pp.338~344 (2013)
6. Bao S, "Glioma stem cells promote radioresistance by preferential activation of the DNA damage response", Nature, 444, pp.756~760 (2006)
7. Jeon HM, "ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2", Cancer Res, 71, pp.3410~3421 (2011)
8. Brooks MD, "Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer", Cell Stem Cell, 17, pp.260~271 (2015)
9. Sun Y, "Treatmentinduced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B", Nat Med, 18, pp.1359~1368 (2012)
10. Plaks V, "The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?", Cell Stem Cell, 16, pp.225~238 (2015)
11. Ricci-Vitiani L, "Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells", Nature, 468, pp.824~828 (2010)
12. Cheng L, "Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth", Cell, 153, pp.139~152 (2013)
13. Petersen OW, "Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma", Am J Pathol, 162, pp.391~402 (2003)
14. Hanahan D, "Hallmarks of cancer: the next generation", Cell, 144, pp.646~674 (2011)
15. Charafe-Jauffret E, "Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature", Cancer Res, 69, pp.1302~1313 (2009)
16. Jiao X, "c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion", J Biol Chem, 285, pp.8218~8226 (2010)
17. Xin YH, "POU5F1 enhances the invasiveness of cancer stem-like cells in lung adenocarcinoma by upregulation of MMP-2 expression", PLoS One, 8, pp.e83373~ (2013)
18. Chen L, "The IL-8", CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases, 2014, pp.4, 5911~
19. Friedl P, "Cancer invasion and the microenvironment: plasticity and reciprocity", Cell, 147, pp.992~1009 (2011)
20. Eppert K, "Stem cell gene expression programs influence clinical outcome in human leukemia", Nat Med, 17, pp.1086~1093 (2011)
21. Piccirillo SG, "Genetic and functional diversity of propagating cells in glioblastoma", Stem Cell Reports, 4, pp.7~15 (2015)
22. Meacham CE, "Tumour heterogeneity and cancer cell plasticity", Nature, 501, pp.328~337 (2013)
23. Chen K, "Understanding and targeting cancer stem cells: therapeutic implications and challenges", Acta Pharmacol Sin, 34, pp.732~740 (2013)
24. Sirko S, "Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog", Cell Stem Cell, 12, pp.426~439 (2013)
25. Yan GN, "Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway", J Pathol, 234, pp.11~22 (2014)
26. Hay ED, "An overview of epithelial-mesenchymal transformation", Acta Anat (Basel), 154, pp.8~20 (1995)
27. Mani SA, "The epithelialmesenchymal transition generates cells with properties of stem cells", Cell, 133, pp.704~715 (2008)
28. Ouyang G, "Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells", Cell Mol Life Sci, 67, pp.2605~2618 (2010)
29. Karin M, "NF-kappa B: linking inflammation and immunity to cancer development and progression", Nat Rev Immunol, 5, pp.749~759 (2005)
30. Li CW, "Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaBmediated transcriptional upregulation of Twist1", Cancer Res, 72, pp.1290~1300 (2012)
31. Li Y, "c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype", Proc Natl Acad Sci U S A, 108, pp.9951~9956 (2011)
32. Takahashi K, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors", Cell, 126, pp.663~676 (2006)
33. Suva ML, "Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells", Cell, 157, pp.580~594 (2014)
34. Lee TK, "CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation", Cell Stem Cell, 9, pp.50~63 (2011)
35. Jeter CR, "NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation", Oncogene, 30, pp.3833~3845 (2011)
36. Rudin CM, "Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer", Nat Genet, 44, pp.1111~1116 (2012)
37. Suvà ML, "Reconstructing and reprogramming the tumor propagating potential of glioblastoma stem-like cells", Cell, 157, pp.580~594 (2014)
38. Li L, "Stem cell niche: structure and function", Annu Rev Cell Dev Biol, 21, pp.605~631 (2005)
39. Plaks V, "The Cancer Stem Cell Niche: How Essential is the Niche in Regulating Stemness of Tumor Cells?", Cell stem cell, 16, pp.225~238 (2015)
40. Kiel MJ, "SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells", Cell, 121, pp.1109~1121 (2005)
41. Oh M, "The Perivascular Niche and Self-Renewal of Stem Cells", Front Physiol, 6, pp.367~ (2015)
42. Calabrese C, "A Perivascular Niche for Brain Tumor Stem Cells", Cancer Cell, 11, pp.69~82 (2007)
43. Charles N, "Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells", Cell Stem Cell, 6, pp.141~152 (2010)
44. Jeon HM, "Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression", Cancer Res, 74, pp.4482~4492 (2014)
45. Yan GN, "Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway", J Pathol, 234, pp.11~22 (2014)
46. Beck B, "A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours", Nature, 478, pp.399~403 (2011)
47. Zhang Z, "Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype", Cancer Res, 74, pp.2869~2881 (2014)
48. Simon MC, "The role of oxygen availability in embryonic development and stem cell function", Nat Rev Mol Cell Biol, 9, pp.285~296 (2008)
49. Jogi A, "Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype", Proc Natl Acad Sci U S A, 99, pp.7021~7026 (2002)
50. Lofstedt T, "Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells", J Biol Chem, 279, pp.39223~39231 (2004)
51. Zhang C, "Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA", Proc Nat Acad Sci U S A, 113, pp.E2047~E2056 (2016)
52. Yang MH, "Direct regulation of TWIST by HIF-1alpha promotes metastasis", Nat Cell Biol, 10, pp.295~305 (2008)
53. Joseph JV, "Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1alpha- ZEB1 axis", Cancer Lett, 359, pp.107~116 (2015)
54. Bao B, "The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness", Biochimica et biophysica acta, 1826, pp.272~296 (2012)
55. Xing F, "Hypoxiainduced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells", Oncogene, 30, pp.4075~4086 (2011)
56. Condeelis J, "Macrophages : Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis", Cell, 124, pp.263~266 (2006)
57. Sullivan NJ, "Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells", Oncogene, 28, pp.2940~2947 (2009)
58. Wu Y, "Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion", Cancer Cell, 15, pp.416~428 (2009)
59. Yu Y, "Cancer-associated fibroblasts induce epithelialmesenchymal transition of breast cancer cells through paracrine TGF-beta signalling", Br J Cancer, 110, pp.724~732 (2014)
60. Vermeulen L, "Wnt activity defines colon cancer stem cells and is regulated by the microenvironment", Nat Cell Biol, 12, pp.468~476 (2010)
61. Hamada S, "Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells", Biochem Biophys Res Commun, 421, pp.349~354 (2012)
62. Lotti F, "Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A", J Exp Med, 210, pp.2851~2872 (2013)
63. Orkin SH, "Chromatin connections to pluripotency and cellular reprogramming", Cell, 145, pp.835~850 (2011)
64. Liang G, "Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective", Cell Res, 23, pp.49~69 (2013)
65. Widschwendter M, "Epigenetic stem cell signature in cancer", Nat Genet, 39, pp.157~158 (2007)
66. Ohm JE, "A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing", Nat Genet, 39, pp.237~242 (2007)
67. Easwaran H, "A DNA hypermethylation module for the stem", progenitor cell signature of cancer, 2012, pp.22, 837~849
68. Rizzo S, "Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2", Mol Cancer Ther, 10, pp.325~335 (2011)
69. Iliopoulos D, "Loss of miR-200 inhibition of Suz12 leads to Polycomb-mediated repression required for the formation and maintenance of cancer stem cells", Mol Cell, 39, pp.761~772 (2010)
70. Crea F, "Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer", Mol Cancer, 10, pp.40~ (2011)
71. Benoit YD, "Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells", Exp Cell Res, 319, pp.1463~1470 (2013)
72. Yang J, "Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells", Proc Nat Acad Sci U S A, 104, pp.10494~10499 (2007)
73. Abdouh M, "BMI1 sustains human glioblastoma multiforme stem cell renewal", J Neurosci, 29, pp.8884~8896 (2009)
74. Pathania R, "DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis", Nat Commun, 6, pp.6910~ (2015)
75. Yang L, "DNMT3A in haematological malignancies", Nat Rev Cancer, 15, pp.152~165 (2015)
76. Heddleston JM, "Hypoxiainduced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential", Cell Death Differ, 19, pp.428~439 (2012)
77. Roesch A, "A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth", Cell, 141, pp.583~594 (2010)
78. Chaffer CL, "Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity", Cell, 154, pp.61~74 (2013)
79. Frank NY, "The therapeutic promise of the cancer stem cell concept", J Clin Invest, 120, pp.41~50 (2010)
80. Schmohl JU, "CD133, Selectively Targeting the Root of Cancer", Toxins (Basel), 8, pp.165~ (2016)
81. Gurney A, "Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors", Proc Natl Acad Sci U S A, 109, pp.11717~11722 (2012)
82. Gavai AV, "Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors", ACS Med Chem Lett, 6, pp.523~527 (2015)
83. Justilien V, "Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells", Clin Cancer Res, 21, pp.505~513 (2015)
84. Huang SD, "Tumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progenies", PLoS One, 8, pp.e54579~ (2013)
85. Kim J, "Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity", Proc Natl Acad Sci U S A, 109, pp.6124~6129 (2012)
86. Patel AP, "Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma", Science, 344, pp.1396~1401 (2014)
87. Meyer M, "Single cellderived clonal analysis of human glioblastoma links functional and genomic heterogeneity", Proc Natl Acad Sci U S A, 112, pp.851~856 (2015)
88. Liu S, "Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts", Stem Cell Reports, 2, pp.78~91 (2014)
89. Brennan CW, "The somatic genomic landscape of glioblastoma", Cell, 155, pp.462~477 (2013)
90. Mao P, "Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3", Proc Natl Acad Sci U S A, 110, pp.8644~8649 (2013)
91. Bhat KP, "Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma", Cancer Cell, 24, pp.331~346 (2013)
92. Das R, "Epithelial plasticity in prostate cancer: principles and clinical perspectives", Trends Mol Med, 20, pp.643~651 (2014)
93. Banyard J, "Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model", Sci Rep, 3, pp.3151~ (2013)
94. Ruscetti M, "HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer", Oncogene, 35, pp.3781~3795 (2016)
95. Ebrahimi B, "Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency", Cell Regen (Lond), 4, pp.10~ (2015)

관련 논문AI추천